Quantinuum's First Earnings After its IPO: Buy or Sell QNT Stock?

Quantinuum priced its upsized initial public offering of 28 million Class A shares at $60 per share on June 3, raising gross proceeds of $1.68 billion before underwriting discounts and offering expenses.

How Are Estimates Poised for Quantinuum?

The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at a loss of 26 cents per share. The estimate has remained unchanged over the past 30 days. The consensus mark for second-quarter revenues is pegged at $7.8 million.

Image Source: Zacks Investment Research

What to Expect From Quantinuum’s Q2 Results

Quantinuum entered the second quarter with modest recognized revenues but a substantially strengthened balance sheet following its IPO.

Based on Quantinuum's IPO prospectus, the company generated first-quarter 2026 net revenues of $5.2 million, down from $19.1 million in the prior-year period. The year-over-year decline primarily reflected the absence of a $16.5 million sales-type lease transaction that was recognized upfront in the first quarter of 2025. This comparison indicates that quarterly revenues can fluctuate sharply depending on the timing and structure of hardware agreements. Cloud-platform, research and support-services revenues increased by $2.5 million in the March quarter, partially offsetting the absence of the large prior-year transaction.

For the second quarter, revenue results are expected to be influenced by contributions from hardware access, cloud utilization, software, research services and support agreements. Further, the company commercially launched Helios in late 2025, with announced customers including Amgen AMGN, BMW Group, JPMorgan Chase JPM and SoftBank SFTBY. This is also expected to have impacted the top-line performance in the second quarter.

Bookings will be another key metric to watch in the second-quarter results. Quantinuum reported bookings of $1.3 million in the first quarter, compared with $1.9 million a year earlier. However, full-year 2025 bookings totaled $79.3 million. Management defines bookings as the aggregate dollar value of customer contracts executed during a period, although their ultimate value can be affected by contract modifications and terminations.

Investments Likely to Keep Losses Elevated in Q2

First-quarter research and development expenses increased 53% year over year to $54.7 million, reflecting spending on outsourced research, personnel, facilities and materials for next-generation quantum systems. Sales and marketing expenses rose to $13.7 million from $3.4 million, while general and administrative expenses increased 58% to $8.7 million.

These trends suggest that operating losses are likely to have been substantial in the second quarter. Quantinuum has stated that it expects to incur losses for the foreseeable future as it invests in research, engineering, manufacturing readiness and commercialization.

For investors’ note, Quantinuum used $62.9 million of cash in operating activities and $22.7 million for capital expenditures during the first quarter. The company had $677 million in cash and cash equivalents as of March 31, before receiving the IPO proceeds.

QNT’s Price Performance

Quantinuum shares advanced 35.3% since their public-market inception, till June 30, the second quarter’s end, outperforming the Internet Software industry’s 5.6% return.

Image Source: Zacks Investment Research

The strong debut indicates that investors have assigned a substantial premium to Quantinuum’s technology platform, commercial partnerships and long-term fault-tolerant quantum-computing roadmap. It also raises the sensitivity of the shares to execution, particularly because current revenues remain small relative to the company’s public-market valuation.

What the Zacks Model Unveils for QNT Stock

Our proven model does not conclusively predict an earnings beat for Quantinuum this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.

Earnings ESP: Quantinuum has an Earnings ESP of 0.00%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.

Zacks Rank: The company currently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Our Take

Despite Quantinuum's differentiated technology, strategic partnerships and solid balance sheet, the stock already reflects high expectations following its strong debut. With limited revenue visibility, elevated operating losses and likely volatility around its first public earnings report, investors may be better served waiting for greater clarity on commercial execution and a more attractive entry point after the second-quarter results.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research